[Side effect of mifepristone in combination with misoprostol for medical abortion]
- PMID: 14989987
[Side effect of mifepristone in combination with misoprostol for medical abortion]
Abstract
Objective: To assess the safety of mifepristone in combination with misoprotol for medical abortion.
Method: Literatures on the safety of medical abortion were searched in 9 databases worldwide and 9 Chinese medical journals.
Results: A total of 101 articles and 1364 women were collected. Severe side effects including allergic or hemorrhagic shock, arrhythmia, convulsion and newborn deformities were observed in 115 cases. A total of 1015 cases appeared vaginal bleeding, mild or moderate allergic reaction. Systematic review found the relative risks (95% confidence interval, CI) of bleeding, abdominal pain, fever and dizziness in the medical abortion population were 3.27 (1.14 - 9.38), 1.63 (1.14 - 2.34), 1.58 (1.03 - 2.44) and 1.36 (1.06 - 1.75), respectively. These were higher in the medical abortion population than that in the surgical abortion population. In addition, the duration of bleeding caused by medical abortion was longer than that caused by surgical abortion. Its weighted mean difference was 6.49 and 95% CI was 6.08 - 7.80.
Conclusions: The incidence of side effects caused by this medical abortion was low. However, attention should be paid in clinical practice to the rare, but severe adverse events caused by this treatment. It is necessary to establish a comprehensive nationwide reporting system for these adverse events.
Similar articles
-
Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.Contraception. 2019 Sep;100(3):178-181. doi: 10.1016/j.contraception.2019.05.006. Epub 2019 May 16. Contraception. 2019. PMID: 31102629
-
Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.Reprod Sci. 2017 May;24(5):731-737. doi: 10.1177/1933719116669055. Epub 2016 Sep 27. Reprod Sci. 2017. PMID: 27678099 Clinical Trial.
-
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.BJOG. 2004 Jul;111(7):715-25. doi: 10.1111/j.1471-0528.2004.00153.x. BJOG. 2004. PMID: 15198763 Clinical Trial.
-
Mifepristone and misoprostol sequential regimen side effects, complications and safety.Contraception. 2006 Jul;74(1):48-55. doi: 10.1016/j.contraception.2006.03.016. Epub 2006 May 15. Contraception. 2006. PMID: 16781261 Review.
-
Medical termination of pregnancy in the early first trimester.J Fam Plann Reprod Health Care. 2005 Jan;31(1):10-4. doi: 10.1783/0000000052972906. J Fam Plann Reprod Health Care. 2005. PMID: 15720840 Review.
Cited by
-
Pain management for medical abortion before 14 weeks' gestation.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013525. doi: 10.1002/14651858.CD013525.pub2. Cochrane Database Syst Rev. 2022. PMID: 35553047 Free PMC article.
-
Acute pancreatitis following medical abortion: Case report.BMC Womens Health. 2004 Apr 6;4(1):1. doi: 10.1186/1472-6874-4-1. BMC Womens Health. 2004. PMID: 15068485 Free PMC article.
-
Experiences of abortion: a narrative review of qualitative studies.BMC Health Serv Res. 2008 Jul 17;8:150. doi: 10.1186/1472-6963-8-150. BMC Health Serv Res. 2008. PMID: 18637178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical